Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

Original article

British care for the mentally ill – a model for Germany?

In order to improve the supply situation for psychotherapy quickly and efficiently, the British Ministry of Health is investing at least 300 million pounds over the next few years. In addition to the existing care system, almost one million patients will be treated by at least 3,600 additional, newly trained psychological therapists. According to the authors, there are also deficiencies in the provision of psychotherapy in Germany. For example, For example, only about one in ten mentally ill patients receive psychotherapy. The waiting times for such a place are almost half a year. When treated, it is usually pharmacotherapeutic, although evidence-based psychotherapies are generally more successful and less expensive than pharmacotherapy for the most common disorders. With long-term thinking, current health economic research data speak in favor of promoting psychotherapy, and suggestions for improving the care situation are then made.

01.06.2009
Institutionalization in dementia – frequency, time and influencing factors

Aging in familiar surroundings is a great need for most people. The transition to a residential care facility, on the other hand, is often experienced as very stressful and is associated with considerable financial costs for those affected, their relatives and social security systems. If people develop dementia, one in two people move permanently into a residential care facility within the first three years of the onset of the illness. Whether and when a move to a residential facility is carried out depends on numerous characteristics of those affected, their relatives and external conditions. For a German sample of older people with incident dementia, the absence of a spouse in particular was identified as a strong risk factor for a shorter time before moving to a residential facility. In addition to identifying further - possibly modifiable - factors influencing the institutionalization rates and times of dementia sufferers, the aim of future research efforts should also be the development of target group-specific interventions for certain risk groups in order to - if sensible - ensure longer or optimal care for dementia patients in the home environment to be able to move into a home facility at the right time.

01.06.2009
Standardized treatment costs lead to more quality in the system

The President of the Federal Insurance Office (BVA), Josef Hecken, in the MVF cover interview

01.04.2009
Achieve a concerted approach to health services research

Staatssekretär Dr. Klaus Theo Schröder im MVF-Titelinterview: ein Jahr Realität in der deutschen Versorgungsforschung

01.04.2009
Importance of oral antidiabetics is increasing

Die medikamentöse Therapie des Diabetes mellitus Typ 2 erfolgt vor allem mit oralen Antidiabetika, im fortgeschrittenen Stadium auch mit Insulinen. Im letzten Jahr stiegen die Ausgaben für orale Antidiabetika mit knapp zwölf Prozent doppelt so stark wie der gesamte Arzneimittelmarkt und repräsentieren innerhalb der GKV mittlerweile ein Ausgabenniveau von über einer halben Milliarde Euro. Zwischen […]

01.04.2009
Too much government

Kommentar von Konrad Schily /FDP

01.04.2009
A common concept is necessary

Peter Schmidt, Progenerika, im Interview mit MVF:

01.04.2009
RCTs: an important instrument in health services research

Discussion about RCT

01.04.2009
Versorgung 2.0: Decision support „in Häppchenform“

Sie ist eine der zentralen Herausforderungen des Gesundheitssystems – die Volkskrankheit Diabetes mellitus Typ 2. Mit einer klar steigenden Tendenz und erheblichem Risikopotenzial für die Versicherten. Doch nicht die Diabetes-Erkrankung an sich schränkt das Leben der Betroffenen ein, erhöht die Sterblichkeit und bedingt einen massiven Ressourceneinsatz des Systems, sondern vielmehr die damit assoziierten Folgeerkrankungen wie […]

01.04.2009
Comparison of treatment costs for insulin-dependent type 2 diabetics in everyday care

LIVE-SPP Study (Long Acting Insulin Glargine Versus NPH Cost Evaluation in Specialized Practices

01.04.2009

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.